Abstract
purpose. To determine whether retinal pigment epithelial (RPE) cells, which
reportedly express N-cadherin as their major cadherin cell adhesion
protein, also express the more common epithelial cadherin, E-cadherin.
methods. Cadherins expressed by human RPE cells in situ were examined by western
blot analysis of extracts prepared from the RPE of human adult eyes.
Cadherins expressed in vitro were examined by analysis of confluent and
postconfluent human RPE cultures, using the methods of reverse
transcription–polymerase chain reaction (RT–PCR) and western blot
analysis. Protein distribution was examined by conventional
fluorescence microscopy, confocal imaging, or both. Proteins whose
expression, distribution, or both correlated with E-cadherin expression
in other epithelial cells were examined by similar methods in cultured
RPE cells.
results. In addition to N-cadherin, E-cadherin (and P-cadherin) was found in
adult human RPE in situ. In cultured human RPE cells, N-cadherin was
ubiquitous, but E-cadherin was limited to patches of cells and was not
expressed until several weeks after confluence, a time when several
phenotypic variants become prominent. E-cadherin was absent from RPE
cells of fusiform shape but was found in only a subset of epithelioid
RPE cells. Unlike epithelial cell lines expressing E-cadherin, cultured
RPE cells with E-cadherin did not show diminished coexpression of
N-cadherin, increased expression of desmosomal proteins, or a
preferential expression of the αE- (rather than α-N) isoform of the
cadherin linker protein α-catenin. Na/K ATPase distributed to both
apical and basolateral membranes in RPE cells with junctional
E-cadherin and not preferentially to the basolateral domain as in most
epithelial cells with E-cadherin.
conclusions. RPE cells express E-cadherin, a cadherin found in most other epithelial
cells, but which was believed to be absent from RPE. In RPE in vitro,
E-cadherin expression is a late developmental event, occurring in late
confluence in cells that already express N-cadherin. E-cadherin is an
established epithelial morphoregulatory protein, but it does not induce
the same properties in RPE cells as in other epithelial cells,
suggesting tissue-specific differences in the potential of E-cadherin
to determine an epithelial phenotype.
In the process of mediating cell–cell attachment, the adhesion
molecule E-cadherin also appears to confer phenotype on cultured
epithelial cells. E-cadherin localizes to junctional sites shortly
after confluence where it triggers the time-dependent development of
polarized plasma membrane domains
1 2 3 4 5 and the acquisition
of a grossly epithelial cell shape. In addition to E-cadherin,
epithelial cells also often express P-cadherin, although little is
known about the morphoregulatory properties of this member of the
cadherin family.
In contrast to most monolayer epithelial cells, cells of the retinal
pigment epithelium (RPE) have been reported to lack
E-cadherin
6 7 8 and to express
N-cadherin,
7 9 10 11 12 which is typically found in
nonepithelial cells. In embryonic chick development, RPE cells have
also been shown to express B-cadherin,
13 which is likely
the avian homologue of mammalian P-cadherin.
14 Aside from
expressing N-cadherin, RPE cells have several other unusual properties
that distinguish them from most epithelia. The RPE monolayer is located
between two tissues rather than facing a lumen, the sodium pump of RPE
cells is reportedly polarized to the apical rather than basolateral
membrane domain,
15 16 17 18 19 20 21 and the RPE of many species,
including humans, lacks desmosomes.
22 Because E-cadherin
plays a role in directing Na/K ATPase polarity
8 23 and
desmosome assembly,
8 24 the unusual molecular properties
of the RPE compared with other epithelial cells might be attributed at
least in part to the absence of E-cadherin in the RPE.
When propagated in vitro, human RPE cells display another feature that
differs from epithelial cell lines. Rather than producing cultures
consisting of cells with a fairly uniform epithelioid phenotype,
confluent monolayers of the RPE are morphologically heterogeneous,
varying in cell shape from epithelioid to fusiform, and phenotype
development occurs over a long postconfluent interval of several
weeks.
25 26 However, it is not a common practice to
maintain cultured cells for protracted postconfluent periods before
analysis of protein expression, so it has not been determined whether
cadherin expression by RPE cells may change in late confluence.
Considering the morphoregulatory function that has been ascribed to the
cadherins, a change in cadherins over time could contribute to late RPE
cell shape development.
Here we reevaluated cadherin expression in RPE cells by examining
cadherin proteins in postconfluent cultures of human RPE. On observing
E-cadherin in some cells in late-stage cultures, we also reexamined
cadherins in situ by preparing RPE extracts from adult human eyes.
Similarly reexamined in cultured cells were other proteins whose
expression, distribution, or both were shown to be related to
E-cadherin expression in other cells. These proteins include desmosomal
proteins desmoglein (dg) and desmoplakin (dp), isoforms of a cadherin
linker protein, αE- and αN-catenin, and Na/K ATPase. We show that,
in contrast to previous reports, RPE cells express E-cadherin both
within the tissue and in culture, although expression in culture is
unusual in that it is restricted to patches of cells and markedly
delayed, occurring after weeks at confluence. We also show that RPE
cells expressing E-cadherin lack several properties that have been
attributed to E-cadherin in other cells, suggesting that the inductive
properties of E-cadherin in epithelial cells are not universal but may
be modulated by tissue-specific factors.
Analysis of E-Cadherin Expression by Reverse
Transcription–Polymerase Chain Reaction and Sequencing
Total RNA was extracted from cultures of RPE cells, A431 cells, or
corneal stroma fibroblasts (CSF) using TRI REAGENT (Molecular Research
Center). Reverse transcription (RT) reactions were carried out using
the GeneAmp RNA PCR Kit (Perkin–Elmer) with the following reaction
mixture: 5 mM MgCl2, 1× polymerase chain
reaction (PCR) buffer, 1 mM dNTPs, 20 U RNase inhibitor, 50 U MuLV
reverse transcriptase, 2.5 μM random hexamer, and 1 μg RNA. The
mixtures were incubated at 42°C for 30 minutes for reverse
transcription, followed by incubation at 99°C for 5 minutes to
inactivate the enzyme.
Primers for the human E-cadherin gene (from Operon Technologies) were
as follows: upstream, 5′-GTGACTGATGCTGATGCCCCCAATACC-3′; downstream,
5′-GACGCAGAATCAGAATTAGGAAAGCAAG-3′.
28 PCRs were performed
in a DNA Thermal Cycler 480 (Perkin–Elmer) and contained 1.5 mM
MgCl
2, 1× PCR buffer, 200 μM dNTPs, 0.4 μM
primers, 2.5 U DNA polymerase (Ampli
Taq Gold,
Perkin–Elmer), and 1 μl cDNA from the RT reaction. Control RT–PCRs
were conducted in the absence of reverse transcriptase or by
substituting water for the RNA extract. The cycling conditions were as
follows: 1 cycle at 95°C for 10 minutes, 57°C for 2 minutes, and
72°C for 2 minutes; 40 cycles at 94°C for 1 minute, 57°C for 2
minutes, and 72°C for 2 minutes; 1 cycle at 94°C for 1 minute,
57°C for 2 minutes, and 72°C for 10 minutes; followed by a hold at
4°C. Amplified PCR products were electrophoresed in 1% agarose gels
containing ethidium bromide. PCR products were sequenced using
Ampli
Taq DNA Polymerase FS and ABI-PRISM fluorescent dye
terminator cycle sequencing (BigDye kit; Perkin-Elmer).
Wholemounts of human RPE cells in situ were prepared by dissecting
the eye to expose the monolayer as described above. Eyecups lined with
the RPE layer were fixed by immersion in methanol for 5 minutes
followed by rinsing in cold (4°C) phosphate-buffered saline. After
fixation, the RPE and underlying choroid was dissected from the sclera,
cut into pieces approximately 5-mm square, processed for
immunofluorescence microscopy as for RPE cultures, and immunostained
with antibodies to E-cadherin as indicated below.
RPE cultures were fixed in 3% paraformaldehyde, permeabilized by
detergent treatment, and immunostained as previously
described.
25 The following primary antibodies were used:
monoclonal antibodies, E-cadherin (Zymed [HECD-1]), P-cadherin, and
desmoglein (Transduction Laboratories); desmoplakins I and II (American
Research Products); N-cadherin ([clone GC4]; Sigma) and pancadherin
(Sigma) and polyclonal antibodies, αE-catenin and αN-catenin (Santa
Cruz Biotechnology); Na/K ATPase (Cortex Biochem [α1β1]); and
pancadherin (Sigma). Appropriate fluorescein isothiocyanate– or
TRITC-conjugated secondary antibodies were from Jackson ImmunoResearch
Laboratories.
Preparations were examined and photographed with a Leitz
epifluorescence microscope or a Bio-Rad MRC-600 confocal microscope.
For the latter, serial 0.2-μm sections were collected through the
thickness of the RPE monolayer to generate cross-sectional Z-scans and
to produce scans from which composite en face images could be
reconstructed.